TREADMILL EXERCISE TEST AND DEVELOPMENT OF HYPERTENSION
Theodoros Kalos,Kyriakos Dimitriadis,Eleni Manta,Ioannis Leontsinis,Sotirios Drogkaris,Fotios Tatakis,Dimitrios Konstantinidis,Fragkoulis Christos,Ioannis Liatakis,Emmanouil Matzouranis,Athanasios Sakalidis,Ioannis Andrikou,Androniki Kakouri,Maria Kouremeti,Konstantinos Tsioufis
DOI: https://doi.org/10.1097/01.hjh.0001020860.10705.33
IF: 4.9
2024-05-01
Journal of Hypertension
Abstract:Objective: Guidelines promote screening people with high normal BP for the presence of end-organ damage because their presence is associated with a 2- to 3-fold increase in the risk of CVD. Design and method: 100 consecutive subjects with high normal BP [systolic BP=130-139mmHg and/or diastolic BP=85-89mmHg] were examined for early signs of hypertension-mediated organ damage (HMOD). They underwent an echocardiographic study, a negative for ischemia treadmill exercise test (Bruce protocol) where the index SBP/MET-slope [(peakSBP—restingSBP)/(peakMET-1)] was used. Arterial stiffness was evaluated based on carotid-femoral pulse wave velocity (PWV). The sympathetic drive was assessed by MSNA. Follow-up was scheduled every 6 months for 3 consecutive years, where BP measurements were assessed in the office and with ambulatory BP monitoring (ABPM). All participants offered lifestyle advice to lower their BP. The endpoint was the development of HTN either with Office BP or ABPM. Results: Of 100 subjects (54±8 years, 42 males, baseline office BP: 132/82 mmHg, 24-hour BP: 122/76 mmHg) 40 developed HTN in 3 years. 34 subjects developed Hypertensive Response to Exercise (HRE) (BP >210mmHg in men and >190mmHg in women) and all of them developed HTN. The SBP/MET-slope in Group I was increased in all stages till peak exercise independently of sex type (stage1: 6.7vs4.9 p=0.049, stage2: 8.4vs4.8 p=0.001, peak: 6.7vs4.9, p=0.001). Their exercise capacity was reduced (10vs11.3METs, p=0.002) as well as their maximum exercise heart rate (156vs164, p=<0.0001). Those with HRE had higher 24hSBP (124vs121mmHg, p=0.009), Night SBP (117vs111mmHg, p<0.001), Day SBP (127vs124mmHg, p=0.012) Office PP (51vs47mmHg, p=0.01), while did not differ regarding their metabolic profile at the follow-up. Additionally, they had increased PWV (8.3vs7.5m/sec, p=<0.0001), MSNA levels (36vs28 bursts, p=<0.0001), LVMI(38vs34 gr/m2, p=0.02), deteriorated 2021 CKD-EPI eGFR (90 vs 97 mL/min/1.73 m 2 , p=0.02). Conclusions: Detecting exaggerated blood pressure response is associated with increased systemic vascular resistance and early subclinical HMOD which may upgrade an individual's cardiovascular disease (CVD) risk as they progress to HTN indicating a need for instituting a BP-lowering strategy.
peripheral vascular disease